Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes

Area of Science:

• Cardiovascular Biology and Disease
• Molecular Cardiology
• Pharmacology

Background:

• Heart failure is a major global cause of mortality.
• Cardiomyocyte hypertrophy, driven by altered gene expression, is central to heart failure progression.
• The transcription factor GATA4 plays a key role in regulating cardiomyocyte hypertrophy.

Purpose of the Study:

• To investigate the potential of curcumin as a novel therapeutic agent for heart failure.
• To explore the p300/GATA4 signaling pathway as a therapeutic target in cardiomyocytes.
• To review recent advancements in cardiac transcriptional signaling and heart failure therapy.

Main Methods:

• Review of existing literature on cardiac transcriptional pathways and heart failure.
• Focus on the role of the p300/GATA4 complex in cardiomyocyte hypertrophy.
• Evaluation of curcumin as a p300 histone acetyltransferase inhibitor.

Main Results:

• The p300/GATA4 complex is crucial for hypertrophic responses in cardiomyocytes.
• Disruption of this complex inhibits hypertrophic signaling.
• Curcumin's inhibition of p300 offers a potential therapeutic strategy.

Conclusions:

• The p300/GATA4 pathway is a critical target for heart failure intervention.
• Curcumin demonstrates potential as a novel pharmacological therapy for heart failure.
• Further research into curcumin-based therapies could lead to effective heart failure treatments.